Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Chiaretti

Showing results (151-160 of 172) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|July 8, 2026
Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocolsFederico Lussana, Giuliana Rizzuto, Alfonso Piciocchi, et al.
Hematological Oncology|October 17, 2022
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biasesRoberta Soscia, Irene Della Starza, Lucia Anna De Novi, et al.
Haematologica|January 13, 2022
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL studyMarco Cerrano, Massimiliano Bonifacio, Matteo Olivi, et al.
British Journal of Haematology|June 25, 2008
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephaseAlexander Kohlmann, Thomas J Kipps, Laura Z Rassenti, et al.
International Journal of Molecular Sciences|June 12, 2026
Comparative Analysis Between the EuroClonality-NGS Approach and the LymphoTrack<sup>®</sup> Dx Assay for IG/TR Marker Screening in Lymphoid Leukemias: A Campus ALL StudyIrene Della Starza, Vittorio Bellomarino, Mariangela Di Trani, et al.
Haematologica|April 21, 2022
COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL reportSabina Chiaretti, Massimiliano Bonifacio, Roberta Agrippino, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemiaAkinori Yoda, Yuka Yoda, Sabina Chiaretti, et al.
Hematological Oncology|August 11, 2025
Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All StudyPatrizia Zappasodi, Ludovica Calabretta, Virginia Valeria Ferretti, et al.
Cancers|September 28, 2023
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All StudyNicola Stefano Fracchiolla, Mariarita Sciumè, Cristina Papayannidis, et al.
American Journal of Hematology|August 11, 2020
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL studyAnna Candoni, Davide Lazzarotto, Felicetto Ferrara, et al.
Pageof 18

Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|July 8, 2026
Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocolsFederico Lussana, Giuliana Rizzuto, Alfonso Piciocchi, et al.
Hematological Oncology|October 17, 2022
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biasesRoberta Soscia, Irene Della Starza, Lucia Anna De Novi, et al.
Haematologica|January 13, 2022
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL studyMarco Cerrano, Massimiliano Bonifacio, Matteo Olivi, et al.
British Journal of Haematology|June 25, 2008
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephaseAlexander Kohlmann, Thomas J Kipps, Laura Z Rassenti, et al.
International Journal of Molecular Sciences|June 12, 2026
Comparative Analysis Between the EuroClonality-NGS Approach and the LymphoTrack<sup>®</sup> Dx Assay for IG/TR Marker Screening in Lymphoid Leukemias: A Campus ALL StudyIrene Della Starza, Vittorio Bellomarino, Mariangela Di Trani, et al.
Haematologica|April 21, 2022
COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL reportSabina Chiaretti, Massimiliano Bonifacio, Roberta Agrippino, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemiaAkinori Yoda, Yuka Yoda, Sabina Chiaretti, et al.
Hematological Oncology|August 11, 2025
Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All StudyPatrizia Zappasodi, Ludovica Calabretta, Virginia Valeria Ferretti, et al.
Cancers|September 28, 2023
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All StudyNicola Stefano Fracchiolla, Mariarita Sciumè, Cristina Papayannidis, et al.
American Journal of Hematology|August 11, 2020
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL studyAnna Candoni, Davide Lazzarotto, Felicetto Ferrara, et al.
Pageof 18